Advances in diagnostic technology are driving the growth of



NEW YORK, April 12, 2018 (GLOBE NEWSWIRE) – The Global point-of-care diagnosis (POCD) Marlet the size should reach, $ 31.32 billion in 2024, To TCCA from 8.87% of 2018 to 2024. The growth of the market is attributed to the growing number of infectious diseases in developing countries, the growing demand for rapid diagnostic solutions and efficient surveillance, and technological advancements such as miniaturization, nanotechnology and microfluidics, as well as the development of new products. In addition, the growing demand in urban areas and the ease of access and simplistic operation of point-of-care diagnostic devices are driving the growth of the market. However, strict government approval policies can hamper market growth.

The report segments the global POCD market into Some products (Blood gas tests, hematology tests, pregnancy and fertility tests, coagulation tests, cholesterol tests, infectious disease tests, cardiac markers, blood sugar tests and others), by Fashion (Over-the-counter (OTC) test kits and prescription test kits), by Final user (Clinics, Home care, Diagnostic centers, Hospitals and Research centers), and by Region (North America, Europe, Asia-Pacific and Rest of the World (RoW))

Point-of-care testing enables medical staff and physicians to accurately obtain real-time, laboratory-grade diagnostic results in minutes, anywhere – at home, in the office and in hospitals. The result of care is both and allows rapid patient care.

Browse Complete Research Report With Table of Contents on “Global Point-of-Service Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation, and Forecast 2024” at:

To purchase a report: [email protected]

Key Findings of the Global Point-of-Care Diagnostics Market

  • Based on product, the blood glucose monitoring segment holds most of the market due to the increasing number of diabetic patients, as well as the increasing adoption of blood glucose monitoring devices.
  • Based on fashion, prescription test kits held most of the market in 2017
  • Based on final user, the clinic segment held the largest share due to limited laboratory infrastructure in rural areas, availability of diagnostic devices in clinics
  • The Asia-Pacific region is expected to experience the fastest growth rate during the forecast period due to increasing demand in developing countries such as China and India, and technological advancements in miniaturization and nanotechnology.
  • The main players in the market are F. Hoffmann-La Roche Ltd; Abbott / Alere; Danaher; Instrumentation laboratory; Nova Biomedical; Trividia Health, Inc .; Quidel Corporation; Trinity Biotech; Sekisui Diagnostics LLC; OraSure Technologies Inc; Johnson & Johnson Services, Inc, and Becton Dickinson & Company (BD); bioMérieux SA; Abaxis; Siemens Healthineers; QIAGEN.

Advances in diagnostic technology are driving the growth of the point-of-care diagnostics market

Diagnostic technology has advanced and developed considerably over the past few years. The growing demand for POCD in the healthcare industry helps doctors and patients to make better decisions, as the results come together in a short period of time, mainly near the patient’s location, which makes the treatment cheaper. Over the past few years, the use of PCOD has increased, the benefit is huge. Point-of-care diagnostic devices are used to diagnose cholesterol and glucose levels, analysis of enzymes and electrolytes, testing for infectious diseases, pregnancy tests, and more. It also plays an important role in the management of patients, reducing the time and allowing rapid treatment of patients. Healthcare researchers conduct clinical trials for the development of easy-to-use diagnostic devices and diagnose other critical illnesses.

Global Point-of-Care Diagnostics Market – Regional Overview

Geographically, the global POCD market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America held the largest market share in 2017 due to the increasing prevalence of infectious diseases and public awareness. In addition, there is the development of new products as well as upcoming government support for the approval of new devices coupled with the adoption of new technology in this region supporting the growth of the industry.

Associated reports

·Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Outlook, Trend and Opportunity Analysis, Competitive Outlook, Exploitable Segmentation, and 2024 Forecast

·Global Sleeping Pills Market Outlook, Trend and Opportunity Analysis, Competitive Outlook, Actionable Segmentation, and Forecast 2024

·Global Sinusitis Treatment Market Outlook, Trend and Opportunity Analysis, Competitive Outlook, Actionable Segmentation, and Forecast 2024

·Global Immune-Mediated Inflammatory Disease Treatment Market Outlook, Trend and Opportunity Analysis, Competitive Outlook, Actionable Segmentation, and 2024 Forecast

About Energias Market Research Pvt. Ltd.

Energias Market Research Pvt. Ltd. publishes high quality reports, in-depth market research, to help clients gain investment level clarity on the current business scenario, trends and segmentation for their future developments. We are committed to meeting the needs of our clients, providing high quality custom reporting solutions best suited to the development and implementation of high Return On Investment (RoI) strategies. We believe that exceptional issues require expertise to be resolved, and with the help of our industry expertise, we are able to offer an in-depth understanding of what is critical, what is applicable and what is needed. is necessary to ensure the success of any business or business.

With a wide range of expertise from various industrial sectors and over 50 industries which includes energy, chemicals and materials, information and communication technologies, semiconductor industries, healthcare and consumer goods, etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.


Mr. Manas Nagi

Business Development Manager

For any questions, write to us: [email protected]

To purchase a report: [email protected]

Call us: + 1-716-239-4915


Source link

Leave A Reply

Your email address will not be published.